| Bioactivity | Prednisolone farnesylate (PNF21) is a new transdermal corticosteroid with anti-inflammatory activity. |
| Invitro | Prednisolone farnesylate is a synthetic glucocorticoid, which is a compound of Prednisolone and its ester Farnesylate and is known to suppress local swelling of the adjuvant-induced arthritis[1]. |
| Name | Prednisolone farnesylate |
| CAS | 118244-44-3 |
| Formula | C36H50O6 |
| Molar Mass | 578.78 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kato N, et al. Treatment of the chronic inflammation in peripheral target tissue improves the crushed nerve recovery in the rat: histopathological assessment of the nerve recovery. J Neurol Sci. 2002 Oct 15;202(1-2):69-74. |